相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells
Stella Cascioferro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Advances in Spirocyclic Hybrids: Chemistry and Medicinal Actions
Mohammed Benadallah et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Highly functionalized pyrrolidine analogues: stereoselective synthesis and caspase-dependent apoptotic activity
Raju Suresh Kumar et al.
RSC ADVANCES (2018)
Recent advances (2015-2016) in anticancer hybrids
Nagaraju Kerru et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Histological analysis of anti-cancer drug loaded, targeted Mn:ZnS quantum dots in metastatic lesions of 4T1 challenged mice
Ibrahim Birma Bwatanglang et al.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2017)
Targeting DNA Minor Groove by Hybrid Molecules as Anticancer Agents
Shalini Nekkanti et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Folic acid targeted Mn:ZnS quantum dots for theranostic applications of cancer cell imaging and therapy
Ibrahim Birma Bwatanglang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system
Ibrahim Birma Bwatanglang et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2016)
Pathophysiological Basis for the Formation of the Tumor Microenvironment
Michael R. Horsman et al.
FRONTIERS IN ONCOLOGY (2016)
Mechanisms of resistance to BCR-ABL TKIs and the therapeutic strategies: A review
Ke Yang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
The use of spirocyclic scaffolds in drug discovery
Yajun Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression
Shaomeng Wang et al.
CANCER RESEARCH (2014)
Two-and Three-dimensional Rings in Drugs
Matteo Aldeghi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2014)
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Kunal Nepali et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of AM-7209, a Potent and Selective 4-Amidobenzoic Acid Inhibitor of the MDM2-p53 Interaction
Yosup Rew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Targeted hyperthermia-induced cancer cell death by superparamagnetic iron oxide nanoparticles conjugated to luteinizing hormone-releasing hormone
Faruq Mohammad et al.
NANOTECHNOLOGY REVIEWS (2014)
Spiro heterocycles as potential inhibitors of SIRT1: Pd/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2′-quinazolines
D. Rambabu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors
Yujun Zhao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Escape from Flatland 2: complexity and promiscuity
Frank Lovering
MEDCHEMCOMM (2013)
New and unusual scaffolds in medicinal chemistry
Charles M. Marson
CHEMICAL SOCIETY REVIEWS (2011)
Therapeutic potential of activators and inhibitors of sirtuins
Aneta Balcerczyk et al.
BIOFACTORS (2010)
The impact of aromatic ring count on compound developability - are too many aromatic rings a liability in drug design?
Timothy J. Ritchie et al.
DRUG DISCOVERY TODAY (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The Sirtuin family: therapeutic targets to treat diseases of aging
Jill C. Milne et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes
B Heltweg et al.
CANCER RESEARCH (2006)
Structure-based design of potent non-peptide MDM2 inhibitors
K Ding et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
分享论文
